SEER Hematopoietic and Lymphoid Neoplasm Database

This neoplasm is not reportable.

Name

T-gamma lymphoproliferative disease

ICD-O-3 Morphology

9768/1: T-gamma lymphoproliferative disorder

Effective 2001 and later

Reportability

This neoplasm is not reportable

Primary Site(s)

No primary site specified

This hematopoietic disease is not reportable for the U.S. except for primary sites C700-C729, C751-C753.
Canada, refer to your specific province for reportability requirements.

Abstractor Notes

T-gamma lymphoproliferative disease is part of the Mature T-cell and NK-cell neoplasms lineage table in the WHO 5th edition of Hematolymphoid Tumors. (See Appendix B in the Hematopoietic Manual, Table B20)

Definition

T-gamma lymphoproliferative disease represents the abnormal expansion of large granular lymphocytes which is reflected by an increase in functionally active NK or ADCC effector cells.

Definitive Diagnostic Methods

This data item does not apply

Immunophenotyping

This data item does not apply

Treatments

Chemotherapy

Corresponding ICD-10 Codes (Cause of Death codes only)

D47.7 Other specified neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue

Corresponding ICD-10-CM Codes (U.S. only)

D47.Z9 Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue (effective October 01, 2015)

Sources

International Classification of Diseases for Oncology, 3rd edition (including revisions). Geneva: World Health Organization, 2001, 2011, 2020.
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577

Glossary